Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Latent Mycobacterium tuberculosis Infection
2015
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer
2007
A priori postulated and real power in cluster randomized trials: mind the gap
2005
Targeted Therapy in Breast Cancer
2004
Predictive value of HER-2 and Topoisomerase IIα in response to primary doxorubicin in breast cancer
2006
Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies
2008
Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group
2005
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Revisiting Rates of Reactivation Tuberculosis
2010
Exploring pathways linking greenspace to health: Theoretical and methodological guidance
2017 Standout
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
2016 Standout
From traditional Chinese medicine to rational cancer therapy
2007 Standout
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
Skp2 and Jab1 Expression Are Associated with Inverse Expression of p27<sup>KIP1</sup> and Poor Prognosis in Oral Squamous Cell Carcinomas
2003
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Regulation of the Cdk inhibitor p27 and its deregulation in cancer
2000
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
2008
Sagittal Knee Kinematics After Rectus Femoris Transfer Without Hamstring Lengthening
2006
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Three Different Binding Sites of Cks1 Are Required for p27-Ubiquitin Ligation
2002 StandoutNobel
Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging
2000
EGF–ERBB signalling: towards the systems level
2006 Standout
Consort 2010 statement: extension to cluster randomised trials
2012 Standout
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment
1999
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Identification of Novel Cellular Targets in Biliary Tract Cancers Using Global Gene Expression Technology
2003
Treatment of latent infection withMycobacterium tuberculosis: update 2010
2010
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
2005
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses
2008
The chemoradiation paradigm in head and neck cancer
2007
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method
2006
Mediators and Moderators of Treatment Effects in Randomized Clinical Trials
2002 Standout
The hallmarks of cancer
2012 Standout
The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27
2001 StandoutNobel
The 17q12-q21 amplicon: Her2 and topoisomerase-IIα and their importance to the biology of solid tumours
2006
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Altered fractionation in the treatment of head and neck cancer
1999
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Regression to the Mean
2003
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
Topoisomerase IIα gene (TOP2A) amplification and deletion in cancer – more common than anticipated
2003
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice
2004 StandoutNobel
A Difference-in-Differences Analysis of Health, Safety, and Greening Vacant Urban Space
2011
Anemia of Chronic Disease
2005 Standout
Breast cancer metastasis: markers and models
2005 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Silicosis
2012 Standout
Immunosenescence and Novel Vaccination Strategies for the Elderly
2013
Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
2008 Standout
Selenium in the Environment, Metabolism and Involvement in Body Functions
2013 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Drugs for preventing lung cancer in healthy people
2020
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Gait Analysis Using Wearable Sensors
2012 Standout
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2004
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
Diagnosis and therapy of oral squamous cell carcinoma
2007
Urban Blight Remediation as a Cost-Beneficial Solution to Firearm Violence
2016
Whatʼs New in Pediatric Orthopaedics
2004 Standout
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
2002 Standout
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Nature and Health
2014 Standout
Mining the National Cancer Institute's Tumor-Screening Database: Identification of Compounds with Similar Cellular Activities
2002
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Adaptive Designs: Terminology and Classification
2006
Ubiquitin-mediated degradation of cellular proteins: why destruction is essential for construction, and how it got from the test tube to the patient's bed.
2001 StandoutNobel
Works of Shande Chen being referenced
Amplification and overexpression of topoisomerase IIalpha predict response to anthracycline-based therapy in locally advanced breast cancer.
2002
Sample Size Estimation for Survival Outcomes in Cluster‐Randomized Studies with Small Cluster Sizes
2000
Rectus Femoris Transfer for Children With Cerebral Palsy: Long-Term Outcome
2003
Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women’s Health Initiative
2017
Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer: 8-year analysis of results
1997
Latent TB Infection Treatment Acceptance and Completion in the United States and Canada
2009
Data quality assurance and quality control measures in large multicenter stroke trials: the African-American Antiplatelet Stroke Prevention Study experience
2001
An efficient multiple-stage procedure for phase II clinical trials that have high response rate objectives
1994
Phase 2 Study of Prolonged Administration of Oral Etoposide in Combination with Weekly Cisplatin in Advanced Non-Small Cell Lung Cancer
1994
Prognostic Significance of p27 Expression in Carcinoma of the Oral Cavity and Oropharynx
1999
Sample Size Estimation in Cluster Randomized Studies with Varying Cluster Size
2001
A More Flexible Regression-to-the-Mean Model with Possible Stratification
1998
Use of Baseline Data for Estimation of Treatment Effects in the Presence of Regression to the Mean
1992
Aging induced decline in T-lymphopoiesis is primarily dependent on status of progenitor niches in the bone marrow and thymus
2012
Rectus Femoris Transfer for Children With Cerebral Palsy: Long-Term Outcome
2003
Use of baseline data for estimation of treatment effects in the presence of regression to the mean.
1992